​

Roivant Sciences (ROIV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Roivant Sciences Revenue Highlights

Latest Revenue (Y)

$124.80M

Latest Revenue (Q)

$2.00M

Main Segment (Y)

Product

Roivant Sciences Revenue by Period

Roivant Sciences Revenue by Year

DateRevenueChange
2024-03-31$124.80M103.65%
2023-03-31$61.28M10.84%
2022-03-31$55.29M132.34%
2021-03-31$23.80M-64.85%
2020-03-31$67.69M-

Roivant Sciences generated $124.80M in revenue during NA 2024, up 103.65% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Roivant Sciences Revenue by Quarter

DateRevenueChange
2025-12-31$2.00M27.24%
2025-09-30$1.57M-27.60%
2025-06-30$2.17M-71.33%
2025-03-31$7.57M-16.06%
2024-12-31$9.02M101.52%
2024-09-30$4.47M-43.99%
2024-06-30$7.99M-11.42%
2024-03-31$9.02M-42.04%
2023-12-31$15.56M326.59%
2023-09-30$3.65M-83.13%
2023-06-30$21.62M-21.01%
2023-03-31$27.38M60.54%
2022-12-31$17.05M21.91%
2021-09-30$13.99M80.83%
2021-06-30$7.74M-48.93%
2021-03-31$15.15M163.41%
2020-12-31$5.75M334.62%
2020-09-30$1.32M-16.05%
2020-06-30$1.58M-97.50%
2020-03-31$62.95M-

Roivant Sciences generated $2.00M in revenue during Q3 2025, up 27.24% compared to the previous quarter, and up 44.67% compared to the same period a year ago.

Roivant Sciences Revenue Breakdown

Roivant Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23
Product$75.06M$28.01M

Roivant Sciences's latest annual revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Sep 23Jun 23
Product Revenue, Net$18.37M$20.67M$18.42M$16.66M

Roivant Sciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product Revenue, Net (100.00%).

Roivant Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAZZJazz Pharmaceuticals$4.27B$1.05B
EXASExact Sciences$3.25B$850.74M
RPRXRoyalty Pharma$2.38B$609.29M
MRNAModerna$1.94B$1.02B
IONSIonis Pharmaceuticals$944.00M$156.72M
BBIOBridgeBio Pharma$362.37M$108.11M
ASNDAscendis Pharma$266.72M$95.89M
ROIVRoivant Sciences$124.80M$2.00M
RNAAvidity Biosciences$18.75M$12.47M
RVMDRevolution Medicines--
SMMTSummit Therapeutics--

ROIV Revenue FAQ

What is Roivant Sciences’s yearly revenue?

Roivant Sciences's yearly revenue for 2024 was $124.8M, representing an increase of 103.65% compared to 2023. The company's yearly revenue for 2022 was $61.28M, representing an increase of 10.84% compared to 2021. ROIV's yearly revenue for 2021 was $55.29M, representing an increase of 132.34% compared to 2020.

What is Roivant Sciences’s quarterly revenue?

Roivant Sciences's quarterly revenue for Q3 2025 was $2M, a 27.24% increase from the previous quarter (Q2 2025), and a -77.83% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.57M, a -27.60% decrease from the previous quarter (Q1 2025), and a -64.89% decrease year-over-year (Q2 2024). ROIV's quarterly revenue for Q1 2025 was $2.17M, a -71.33% decrease from the previous quarter (Q4 2024), and a -72.84% decrease year-over-year (Q1 2024).

What is Roivant Sciences’s revenue growth rate?

Roivant Sciences's revenue growth rate for the last 3 years (2021-2024) was 125.73%, and for the last 5 years (2019-2024) was 84.37%.

What are Roivant Sciences’s revenue streams?

Roivant Sciences's revenue streams in r 24 are Product

What is Roivant Sciences’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Roivant Sciences was Product. This segment made a revenue of $75.06M, representing 100.00% of the company's total revenue.